3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents

Development of novel agents that prevent thrombotic events is an urgent task considering increasing incidence of cardiovascular diseases and coagulopathies that accompany cancer and COVID-19. Enzymatic assay identified novel GSK3β inhibitors in a series of 3-arylidene-2-oxindole derivatives. Conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Babkov, Denis, Bezsonova, Elena, Sirotenko, Viktor, Othman, Elias, Klochkov, Vladlen, Sosonyuk, Sergey, Lozinskaya, Natalia, Spasov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088290/
https://www.ncbi.nlm.nih.gov/pubmed/37054760
http://dx.doi.org/10.1016/j.bmcl.2023.129283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088290/
https://www.ncbi.nlm.nih.gov/pubmed/37054760
http://dx.doi.org/10.1016/j.bmcl.2023.129283

Ejemplares similares